Chemistry, structure & pharmacokinetics

How a glucagon backbone becomes a once-weekly drug

Survodutide starts life as a glucagon-shaped peptide, then gets two crucial edits: substitutions that raise its grip on the GLP-1 receptor, and a greasy fatty-acid tail that lets it cling to blood proteins for days. This unit builds the molecule piece by piece, then follows how that tail turns a fast hormone into a drug you inject once a week.

Understanding the acylation trick and the balanced-agonism tuning unlocks everything practical that follows: the weekly rhythm, the slow dose titration, and why the glucagon signal is deliberately kept partial rather than full.